Oakmont Partners »

Drugs Made In Amer Acqutn shares owned by Oakmont Partners

Quarter-by-quarter ownership of Drugs Made In Amer Acqutn (DMAA) shares owned by Oakmont Partners from 13F filings

Historical chart of Oakmont Partners investment in Drugs Made In Amer Acqutn

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In Amer Acqutn held by Oakmont Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In Amer Acqutn by Oakmont Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $374k 36k 10.27

More positions owned by Oakmont Partners

Kla Corp Com New (KLAC)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Spdr Series Trust Portfolio S&p600 (SPSM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)

View all positions for Oakmont Partners

Top funds holding Drugs Made In Amer Acqutn

Karpus Investment Management
Vivaldi Asset Management
Polar Securities
Glazer Capital
Westchester Capital Management
Hudson Bay Capital Management
Wolverine Asset Management
Mizuho Securities Usa
Aristeia Capital
D. E. Shaw & Co
Heights Capital Management
Radcliffe Capital Management
LMR Partners
Boothbay Fund Management
Atw Spac Management

View all funds holding Drugs Made In Amer Acqutn